TrialBreast cancer research and treatment2021

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.

Foluso O Ademuyiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.